Latest filing published 31 May 2017 for Edwards Lifesciences Corp, €397k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Patrick B. Verguet: trading record in brief
Patrick B. Verguet discloses dealings in Edwards Lifesciences Corp to SEC (Form 4). We count 214 filings; the first trade dates from 25 April 2006 and the latest from 31 May 2017.
Every open-market trade on record is a sale: 108 sales worth €53.7M. The rest of the record consists of 11 share grants and 95 option exercises. In 2017 alone, the filings show no purchases and 11 sales.
The record was last updated on 31 May 2017 with an option exercise (€397k) in Edwards Lifesciences Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrick B. Verguet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$44.621.9% of flowCommon StockSEC:0001225208-17-010625:0
- 10,000 shares@ US$114.884.8% of flowCommon StockSEC:0001225208-17-010625:1
- 8,000 shares@ US$44.621.5% of flowCommon StockSEC:0001225208-17-010120:0
- 4,631 shares@ US$113.212.2% of flowCommon StockSEC:0001225208-17-010120:1
- 8,000 shares@ US$113.153.8% of flowCommon StockSEC:0001225208-17-010120:2
- 10,000 shares@ US$44.621.9% of flowCommon StockSEC:0001225208-17-010120:3
- 10,000 shares@ US$113.134.8% of flowCommon StockSEC:0001225208-17-010120:4
- 7,000 shares@ US$44.621.3% of flowCommon StockSEC:0001225208-17-009815:0
- 7,000 shares@ US$110.683.3% of flowCommon StockSEC:0001225208-17-009815:1
- 1,900 shares@ US$113.130.9% of flowCommon StockSEC:0001225208-17-009815:2
- 2,600 shares@ US$113.131.3% of flowCommon StockSEC:0001225208-17-009815:3
- 494 shares@ US$110.580.2% of flowCommon StockSEC:0001225208-17-009628:1
- 9,625 shares0Common StockSEC:0001225208-17-009628:0
- 24,000 shares@ US$25.482.6% of flowCommon StockSEC:0001225208-17-008604:0
- 6,705 shares@ US$108.363.1% of flowCommon StockSEC:0001225208-17-008604:1
- 7,636 shares@ US$110.083.6% of flowCommon StockSEC:0001225208-17-008604:2
- 9,659 shares@ US$109.334.5% of flowCommon StockSEC:0001225208-17-008604:3
- 24,000 shares@ US$25.482.7% of flowCommon StockSEC:0001225208-17-007147:0
- 24,000 shares@ US$93.909.9% of flowCommon StockSEC:0001225208-17-007147:1
- 5,000 shares@ US$25.480.5% of flowCommon StockSEC:0001225208-16-038463:0
- 5,000 shares@ US$114.882.4% of flowCommon StockSEC:0001225208-16-038463:1
- 10,000 shares@ US$25.481.1% of flowCommon StockSEC:0001225208-16-038312:0
- 92 shares@ US$117.160.0% of flowCommon StockSEC:0001225208-16-038312:1
- 10,000 shares@ US$117.544.9% of flowCommon StockSEC:0001225208-16-038312:2
- 5,000 shares@ US$25.480.5% of flowCommon StockSEC:0001225208-16-038312:3
25 of 214 declarations
